Zoetis names Jay Saccaro as CFO and COO effective August 2026

Zoetis Inc. (NYSE: ZTS) has appointed James (Jay) Saccaro as Executive Vice President, Chief Financial Officer and Chief Operating Officer, effective August 17, 2026, according to a company statement.

The role is newly created and will have Saccaro overseeing Zoetis' global finance function, including capital allocation, financial strategy, reporting, controls, and investor engagement, as well as Global Manufacturing and Supply operations.

Saccaro joins Zoetis from GE HealthCare, where he served as Vice President and CFO since 2023. Before that, he spent more than two decades at Baxter International Inc., including eight years as Executive Vice President and CFO. He also previously held the CFO role at Hill-Rom Corporation. Saccaro holds a bachelor's degree in economics and a master's degree in engineering-economic systems from Stanford University.

Current CFO Wetteny Joseph will transition to the role of Special Advisor to the CEO on financial matters on August 17, 2026, and is expected to remain in that capacity until early 2027 to support the leadership transition.

"Jay brings a unique combination of skills to this newly created leadership position," said Kristin Peck, Chief Executive Officer of Zoetis. "He is a seasoned finance executive with 12 years of CFO experience at some of the world's leading healthcare companies."

Joseph, who joined Zoetis five years ago, said he remains "confident in Zoetis' strategy, people and long-term opportunities."

You May Also Be Interested In

• Faraday Future signs robotics distributor deal, plans partner event
• RenovoRx regains Nasdaq minimum bid price compliance
• Kairos Pharma announces 1-for-7 reverse stock split